Advicenne Pharma
Clinical trials sponsored by Advicenne Pharma, explained in plain language.
-
Withdrawn trial tested new drug to control rare kidney stone disease
Disease control TerminatedThis study aimed to test different doses of an experimental drug called ADV7103 for people with cystinuria, a rare condition that causes painful kidney stones. The goal was to see if the drug could safely and effectively raise urine pH to help prevent stone formation. The trial w…
Phase: PHASE2, PHASE3 • Sponsor: Advicenne Pharma • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Extended trial for kidney acidosis treatment halted before starting
Disease control TerminatedThis study aimed to check the long-term safety and effectiveness of a medication called ADV7103 for people with primary distal renal tubular acidosis (dRTA), a rare condition where the kidneys can't properly remove acid from the blood. It was designed for people who had been in a…
Phase: PHASE3 • Sponsor: Advicenne Pharma • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC